Phase I trial of MA09-retinal-pigment-epithelial-cell-replacement-therapy-Advanced-Cell-Technology (RPE cells) in Asian patients with Stargardt's macular degeneration and dry age-related macular degeneration

Trial Profile

Phase I trial of MA09-retinal-pigment-epithelial-cell-replacement-therapy-Advanced-Cell-Technology (RPE cells) in Asian patients with Stargardt's macular degeneration and dry age-related macular degeneration

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Feb 2016

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top